| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
15,030,000 |
| Market
Cap: |
25.63(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.45 - $2.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rafael Holdings holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets. Co. has an investment in Rafael Pharmaceuticals, Inc., a late-stage cancer metabolism-based therapeutics company. In addition, Co. has established the Barer Institute as an early-stage small molecule research institute that develops therapeutic compounds, including compounds to regulate cancer metabolism with application in other indications beyond cancer. Co. also holds a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage oncological pharmaceutical company based in Israel. Co.'s commercial real estate holdings include the building in Newark, NJ.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
3,225,806 |
| Total Buy Value |
$0 |
$0 |
$0 |
$5,999,999 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
225,122 |
| Total Sell Value |
$0 |
$0 |
$0 |
$423,290 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
6 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jonas Howard S |
Executive Chairman |
• • – |
2024-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
348,259 |
563,538 |
|
- |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2024-04-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(348,259) |
0 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2024-03-21 |
4 |
A |
$1.71 |
$26,381 |
D/D |
15,473 |
534,044 |
|
- |
|
| Polinsky David |
Chief Financial Officer |
• – – |
2024-03-21 |
4 |
D |
$1.71 |
$3,922 |
D/D |
(2,300) |
157,362 |
|
- |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2024-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
348,259 |
348,259 |
|
- |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2024-01-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(348,259) |
215,279 |
|
- |
|
| Bernstein Susan Y |
|
– • – |
2024-01-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,600 |
|
-6% |
|
| Bernstein Susan Y |
|
– • – |
2024-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,600 |
|
-6% |
|
| Weiss Michael J |
Director |
– • – |
2024-01-05 |
4 |
A |
$1.81 |
$50,056 |
D/D |
27,655 |
74,950 |
|
- |
|
| Mccamish Mark Anthony |
Director |
– • – |
2024-01-05 |
4 |
A |
$1.81 |
$50,056 |
D/D |
27,655 |
60,241 |
|
- |
|
| Greenberg Stephen M |
Director |
– • – |
2024-01-05 |
4 |
A |
$1.81 |
$50,056 |
D/D |
27,655 |
74,950 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2023-12-21 |
4 |
A |
$1.82 |
$24,756 |
D/D |
13,602 |
549,517 |
|
- |
|
| Polinsky David |
Chief Financial Officer |
• – – |
2023-12-21 |
4 |
D |
$1.82 |
$15,610 |
D/D |
(8,577) |
159,662 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2023-10-25 |
4 |
A |
$1.52 |
$60,600 |
D/D |
40,000 |
563,119 |
|
- |
|
| Polinsky David |
Chief Financial Officer |
• – – |
2023-10-25 |
4 |
A |
$1.52 |
$60,600 |
D/D |
40,000 |
168,239 |
|
- |
|
| Polinsky David |
Chief Financial Officer |
• – – |
2023-09-23 |
4 |
D |
$2.04 |
$5,171 |
D/D |
(2,541) |
128,239 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2023-09-21 |
4 |
D |
$2.21 |
$30,140 |
D/D |
(13,669) |
523,119 |
|
- |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2023-08-28 |
4 |
A |
$2.24 |
$250,000 |
D/D |
111,408 |
563,538 |
|
- |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2023-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
787,163 |
787,163 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2023-06-21 |
4 |
D |
$2.15 |
$32,616 |
D/D |
(15,170) |
536,788 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2023-03-21 |
4 |
D |
$1.67 |
$26,094 |
D/D |
(15,625) |
551,958 |
|
- |
|
| Polinsky David |
Chief Financial OfficerOfficer |
• – – |
2023-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
130,780 |
|
11% |
|
| Weiss Michael J |
Director |
– • – |
2023-01-05 |
4 |
A |
$1.84 |
$50,000 |
D/D |
27,174 |
47,295 |
|
- |
|
| Pasche Boris C |
Director |
– • – |
2023-01-05 |
4 |
A |
$1.84 |
$50,000 |
D/D |
27,174 |
47,295 |
|
- |
|
| Greenberg Stephen M |
Director |
– • – |
2023-01-05 |
4 |
A |
$1.84 |
$50,000 |
D/D |
27,174 |
47,295 |
|
- |
|
79 Records found
|
|
Page 1 of 4 |
|
|
